polysorbate 80

DRUG3 trials

Sponsors

Tourmaline Bio Inc., Nicolaus Copernicus University, The Calcutta Medical Research Institute

Conditions

Acute Coronary Syndrom (ACS)Health Condition 1: null- Those undergoing cataract surgery by standard phacoemulsification and hydrophobic foldable intraocular lens implantationThyroid Eye Disease

Phase 2

A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants with Thyroid Eye Disease.

RecruitingCTIS2024-514801-69-00

Tourmaline Bio Inc.Thyroid Eye Disease

Start: 2025-04-02Target: 48Updated: 2026-01-22

Phase 3

Evaluation of safety and efficacy of two ticagrelorbased de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicenter, double-blind ELECTRA RCT study.

Active, not recruitingCTIS2024-518090-34-00

Nicolaus Copernicus UniversityAcute Coronary Syndrom (ACS)

Start: 2022-02-07Target: 4500Updated: 2024-11-24

Unknown Phase

Need for steroid use after routine cataract surgery

Active, not recruitingCTRI/2016/04/006806

The Calcutta Medical Research InstituteHealth Condition 1: null- Those undergoing cataract surgery by standard phacoemulsification and hydrophobic foldable intraocular lens implantation

Target: 240Updated: 2021-11-24